Join to view full profile
1475 NW 12th AveFLMiami, FL 33136
Phone+1 305-243-6608
Fax+1 305-243-4975
Dr. Singal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rakesh Singal is an oncology specialist based in Miami, Florida, with a focus on genitourinary oncology. He completed his medical education and training at institutions including Maulana Azad Medical College, The MetroHealth System/Case Western Reserve University, and the University of Minnesota. Dr. Singal has extensive experience in treating different types of cancer such as prostate, kidney, bladder, testicular, and penile cancer. He has contributed significantly to medical research with numerous publications in esteemed journals, including the Journal for Immunotherapy of Cancer and Anticancer Research. Dr. Singal has also led and participated in several clinical trials, further expanding his contributions to cancer research and treatment. He has been recognized with awards such as CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR and has been designated as a Super Doctor by SuperDoctors.com.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1994 - 1998
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1992 - 1994
Maulana Azad Medical CollegeClass of 1984
Certifications & Licensure
FL State Medical License 2002 - 2027
LA State Medical License 1999 - 2003
MN State Medical License 1995 - 2003
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
- MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12
- Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management
Publications & Presentations
PubMed
- Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation.Alireza Abdshah, Mohammad Alyamani, Robert A Burgess, Dipen J Parekh, Benjamin Spieler
The Prostate. 2026-05-01 - Uncommon Manifestation of Oligometastatic Prostate Cancer: Sister Mary Joseph Nodule.Cibele Luna, Oleksandr N Kryvenko, Jose Martinez, Rakesh Singal, Russ Kuker
Clinical Nuclear Medicine. 2023-05-01 - 113 citationsSafety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.Scott S Tykodi, Lucio N Gordan, Robert S Alter, Edward Arrowsmith, Michael R Harrison
Journal for Immunotherapy of Cancer. 2022-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
